BioSyent Inc. (TSXV:RX)
Canada · Delayed Price · Currency is CAD 15.31
+0.11 (0.72%)
At close: Mar 18, 2026
BioSyent Market Cap
BioSyent has a market cap or net worth of CAD 176.03 million as of March 18, 2026. Its market cap has increased by 40.78% in one year.
Market Cap
176.03M
Enterprise Value
153.52M
Revenue
42.18M
Ranking
n/a
PE Ratio
20.50
Stock Price
15.31
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 13.21M to 176.03M, an increase of 1,232.96%. That is a compound annual growth rate of 9.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 176.03M | 22.78% |
| Dec 31, 2025 | 143.37M | 12.27% |
| Dec 31, 2024 | 127.69M | 17.76% |
| Dec 29, 2023 | 108.44M | 28.05% |
| Dec 30, 2022 | 84.69M | -18.50% |
| Dec 30, 2021 | 103.91M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 277.68M |
| Aurora Cannabis | 269.37M |
| Organigram Global | 265.86M |
| Cannara Biotech | 176.82M |
| Auxly Cannabis Group | 168.60M |
| Cardiol Therapeutics | 161.97M |
| Ascend Wellness Holdings | 141.18M |
| HLS Therapeutics | 137.60M |